OTCMKTS:VBIO

Vitality Biopharma Stock Forecast, Price & News

$0.17
-0.06 (-26.09 %)
(As of 03/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.17
Now: $0.17▼
$0.23
50-Day Range
$0.08
MA: $0.20▼
$0.32
52-Week Range
$0.02
Now: $0.17▼
$0.55
Volume163,893 shs
Average Volume57,313 shs
Market Capitalization$8.64 million
P/E RatioN/A
Dividend YieldN/A
Beta3.26
Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.
Vitality Biopharma logo

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:VBIO
Previous SymbolOTCMKTS:STVF
CUSIPN/A
CIK1438943
Webwww.vitality.bio
Phone530-231-7800
Employees3
Year FoundedN/A

Debt

Debt-to-Equity Ratio0.14
Current Ratio1.23
Quick Ratio1.23

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$260,000.00
Price / Sales33.24
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.03 per share
Price / Book5.67

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-4,360,000.00
Net MarginsN/A
Return on Equity-259.25%
Return on Assets-116.33%

Miscellaneous

Outstanding Shares50,840,000
Market Cap$8.64 million
Next Earnings Date7/5/2021 (Estimated)
OptionableNot Optionable

Headlines

Vitality Biopharma Inc
October 15, 2020 |  bloomberg.com
Vitality Biopharma Hires Investment Bank To Explore M&A, Asset Sale Opportunities
September 25, 2020 |  benzinga.com
Cannabis Stock Gainers And Losers From September 1, 2020
September 3, 2020 |  msn.com
Vitality Biopharma Receives $8.5 Million Common Stock Financing
July 23, 2020 |  www.bloomberg.com
Vitality Biopharma, Inc. (VBIO)
July 4, 2020 |  finance.yahoo.com
Vitality Biopharma Board Update
April 27, 2020 |  finance.yahoo.com
Vitality Biopharma Introduces Cannabinoid Pharmaceutical VITA-100 as Prodrug of THC
March 20, 2020 |  www.bloomberg.com
Vitality Biopharma Files Intellectual Property in All Major Pharmaceutical Markets Worldwide
March 18, 2020 |  www.bloomberg.com
Vitality Biopharma Receives Updated SeeThruEquity Price Target of $2.40
January 1, 2020 |  www.bloomberg.com
Vitality Biopharma Inc.
October 11, 2019 |  www.barrons.com
Vitality Biopharma Welcomes New Executive Management Team
May 14, 2019 |  finance.yahoo.com
Vitality Biopharma Co-Founder Dr. Avtar Dhillon Resigns from Board of Directors
April 25, 2019 |  finance.yahoo.com
Vitality Biopharma Appoints Former Ohio Governor Richard F. Celeste to Board - GlobeNewswire
January 25, 2019 |  globenewswire.com
Vitality Biopharma Appoints Former Ohio Governor Richard F. Celeste to Board
January 24, 2019 |  finance.yahoo.com
See More Headlines

MarketRank™

Overall MarketRank™

0.52 out of 5 stars

Medical Sector

1483rd out of 1,996 stocks

Commercial Physical Research Industry

29th out of 42 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.17
-0.06 (-26.09 %)
(As of 03/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for VBIO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Vitality Biopharma (OTCMKTS:VBIO) Frequently Asked Questions

What stocks does MarketBeat like better than Vitality Biopharma?

Wall Street analysts have given Vitality Biopharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Vitality Biopharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Vitality Biopharma's next earnings date?

Vitality Biopharma is scheduled to release its next quarterly earnings announcement on Monday, July 5th 2021.
View our earnings forecast for Vitality Biopharma.

How has Vitality Biopharma's stock been impacted by Coronavirus (COVID-19)?

Vitality Biopharma's stock was trading at $0.08 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, VBIO shares have increased by 112.5% and is now trading at $0.17.
View which stocks have been most impacted by COVID-19.

Who are Vitality Biopharma's key executives?

Vitality Biopharma's management team includes the following people:
  • Hon. Edward Farrell Feighan, Exec. Chairman (Age 73, Pay $123.5k)
  • Mr. Michael R. Cavanaugh CPA, J.D., CEO & Director
  • Mr. Richard McKilligan J.D., M.B.A., CFO, Counsel & Sec. (Age 57, Pay $185k)
  • Dr. Brandon Joel Zipp, Scientific Co-Founder & Chief Science Officer (Age 40)
  • Dr. J. Jeremiah Mann, VP of Operations & Sr. Agronomist
  • Dr. Dong Yuejin, Partner

Who are some of Vitality Biopharma's key competitors?

Some companies that are related to Vitality Biopharma include HedgePath Pharmaceuticals (HPPI), Tenax Therapeutics (TENX), U.S. Stem Cell (USRM), Protalex (PRTX), DNAPrint Genomics (DNAG), Affinity Energy and Health (ALGXY), Deltagen (DGEN) and Redpoint Bio (RPBC).
View all of VBIO's competitors.

What other stocks do shareholders of Vitality Biopharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vitality Biopharma investors own include Cannabics Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), Pennsylvania Real Estate Investment Trust (PEI), OrganiGram (OGI), KushCo (KSHB), PotNetwork (POTN), MariMed (MRMD), Medical Marijuana (MJNA), MassRoots (MSRT) and The Supreme Cannabis (SPRWF).

What is Vitality Biopharma's stock symbol?

Vitality Biopharma trades on the OTCMKTS under the ticker symbol "VBIO."

How do I buy shares of Vitality Biopharma?

Shares of VBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vitality Biopharma's stock price today?

One share of VBIO stock can currently be purchased for approximately $0.17.

How much money does Vitality Biopharma make?

Vitality Biopharma has a market capitalization of $8.64 million and generates $260,000.00 in revenue each year.

How many employees does Vitality Biopharma have?

Vitality Biopharma employs 3 workers across the globe.

What is Vitality Biopharma's official website?

The official website for Vitality Biopharma is www.vitality.bio.

Where are Vitality Biopharma's headquarters?

Vitality Biopharma is headquartered at 1901 AVENUE OF THE STARS 2ND FLOOR, LOS ANGELES CA, 90067.

How can I contact Vitality Biopharma?

Vitality Biopharma's mailing address is 1901 AVENUE OF THE STARS 2ND FLOOR, LOS ANGELES CA, 90067. The company can be reached via phone at 530-231-7800 or via email at [email protected]


This page was last updated on 3/23/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257
MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement
Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.

Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.